Published in J Clin Pathol on October 01, 1980
The use of purified 125-I-labelled anti-gamma globulin in the determination of the number of D antigen sites on red cells of different phenotypes. Vox Sang (1966) 3.22
Preparation of red cells coated with C4 and C3 subcomponents and production of anti-C4d and anti-C3d. Vox Sang (1976) 1.15
Autoimmune haemolytic anaemias. 3. Preparation and examination of specific antisera against complement components and products, and their use in serological studies. Clin Exp Immunol (1970) 1.15
Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome. J Clin Invest (1973) 1.10
Detection of bound C3 by a new immunochemical methods. J Immunol (1971) 1.06
Clinical usefulness of specific antiglobulin reagents in autoimmune hemolytic anemias. Prog Hematol (1973) 1.01
The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera. Transfusion (1976) 0.89
Comparison of low-molecular-weight products following reaction of C3-C3b with C3b inactivator and with trypsin. Vox Sang (1977) 0.86
Correlations between quantitative assay of red cell-bound C3, serologic reactions, and hemolytic anemia. Blood (1974) 0.86
Quantification of antibodies to the C3d subcomponent of human C3. Immunology (1977) 0.86
Further observations on the preparation of antiglobulin reagents reacting with c3d and c4d on red cells. Vox Sang (1977) 0.85
Evaluation of commercial antiglobulin sera over a two-year period. Part I. Anti-beta 1A, anti-alpha 2D, and anti-beta 1E levels. Transfusion (2003) 0.81
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol (1997) 2.71
Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill (2014) 2.02
Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol (1998) 1.92
Nama keratopathy. Br J Ophthalmol (1973) 1.87
Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol (1992) 1.83
CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials. Br J Cancer (2005) 1.81
Evaluation of measures used to assess quality of life after stroke. Stroke (2000) 1.80
Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost (2005) 1.70
A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary. Eur J Cancer (2003) 1.45
Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole. Am J Hematol (1995) 1.45
A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion (1996) 1.44
Prenatal diagnosis of neonatal alloimmune thrombocytopenia using an allele-specific oligonucleotide probe. Prenat Diagn (1993) 1.40
Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood (1991) 1.29
Trabeculectomy in a Black American glaucoma population. Br J Ophthalmol (1976) 1.23
Scleral patch grafts with Molteno setons. Ophthalmic Surg (1987) 1.23
Acute urinary retention--a urodynamic assessment. Br J Urol (1984) 1.20
Optimal conditions for the use of sulphydryl compounds in dissociating red cell antibodies. Vox Sang (1976) 1.19
Thrombin-triggered platelet apoptosis. J Thromb Haemost (2006) 1.18
Rapid separation of CD4+ and CD19+ lymphocyte populations from human peripheral blood by a magnetic activated cell sorter (MACS). Cytometry (1993) 1.17
Survey of ocular disease among the Nama people of South West Africa. Br J Ophthalmol (1973) 1.16
Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion (2001) 1.16
Activation of the alternative pathway by gluten. A possible aetiological factor in dermatitis herpetiformis. Immunology (1977) 1.15
Survey of the UK veterinary profession: common species and conditions nominated by veterinarians in practice. Vet Rec (2014) 1.15
Preparation of red cells coated with C4 and C3 subcomponents and production of anti-C4d and anti-C3d. Vox Sang (1976) 1.15
Rapid ambulance protocol for acute stroke. Lancet (1999) 1.12
Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr (1997) 1.10
Endophthalmitis after trabeculectomy. Arch Ophthalmol (1978) 1.07
Incidence of retinoblastoma in the Bantu of South Africa. Br J Ophthalmol (1976) 1.07
Bilateral macular coloboma, keratoconus, and retinitis pigmentosa. Ann Ophthalmol (1971) 1.07
Comparative study of Watson's and Cairns's trabeculectomies in a Black population with open angle glaucoma. Br J Ophthalmol (1977) 1.06
Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost (2006) 1.06
Fluorescein fundus angiography in self-induced solar retinopathy. A case report. Can J Ophthalmol (1971) 1.06
Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann N Y Acad Sci (2000) 1.05
Corneal transplantation with associated histopathologic description in xeroderma pigmentosum occurring in a black family. Ann Ophthalmol (1979) 1.05
Delivering labeled teaching images over the Web. Proc AMIA Symp (1998) 1.04
Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arterioscler Thromb Vasc Biol (1999) 1.04
HLA antigens in acute anterior uveitis in South African blacks. Br J Ophthalmol (1980) 1.00
Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost (2006) 1.00
Coexistence of neuronal messengers--an overview. Prog Brain Res (1986) 0.99
IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity. Br J Haematol (2001) 0.96
Humoral and cellular immune abnormalities in adult hemophiliacs followed over a 2-year period. Diagn Clin Immunol (1987) 0.96
Transcatheter coil embolisation: a novel definitive treatment option for intralobar pulmonary sequestration. Heart Lung Circ (2010) 0.95
Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure. Br J Haematol (1997) 0.95
Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer. Br J Cancer (2003) 0.94
Clinical trial: 2-L polyethylene glycol-based lavage solutions for colonoscopy preparation - a randomized, single-blind study of two formulations. Aliment Pharmacol Ther (2010) 0.94
Histopathologic study of the Molteno glaucoma implant in three patients. Am J Ophthalmol (1990) 0.93
Membrane-bound immunoglobulins and complement components on young and old red cells. Transfusion (1985) 0.93
Antinociceptive effects and spinal cord tissue concentrations after intrathecal injection of guanfacine or clonidine into rats. Anesth Analg (1987) 0.93
Procoagulant surface exposure and apoptosis in rabbit platelets: association with shortened survival and steady-state senescence. J Thromb Haemost (2004) 0.92
Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action. Transfus Sci (1998) 0.92
Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens. Blood (2000) 0.91
Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP). Br J Haematol (1996) 0.91
Bariatric surgery reduces mortality in Swedish men. Br J Surg (2010) 0.90
Urodynamics of the female lower urinary tract. Urol Clin North Am (1985) 0.90
Higher thrombin concentrations are required to induce platelet apoptosis than to induce platelet activation. Br J Haematol (2007) 0.89
Relationship of myoma cell size and menopausal status in small uterine leiomyomas. Arch Pathol Lab Med (2000) 0.89
Complement activation by Corynebacterium acnes. Br J Dermatol (1978) 0.89
A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer. Ann Oncol (2003) 0.88
Cavitating pneumonia caused by Corynebacterium group JK. J Clin Microbiol (1988) 0.88
Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity. Blood (1999) 0.88
Various parameters of diabetic retinopathy among clinic populations. Ann Ophthalmol (1975) 0.87
Dahlak blindness. Br Med J (1972) 0.87
The structure and binding characteristics of serum amyloid protein (9.5S alpha 1-glycoprotein). Ann N Y Acad Sci (1982) 0.87
Comparison of low-molecular-weight products following reaction of C3-C3b with C3b inactivator and with trypsin. Vox Sang (1977) 0.86
Quantification of antibodies to the C3d subcomponent of human C3. Immunology (1977) 0.86
Antinociceptive and 'neurotoxic' actions of somatostatin in rat spinal cord after intrathecal administration. Pain (1988) 0.86
The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol (1998) 0.85
Phase I study of irinotecan and raltitrexed in patients with advanced gastrointestinal tract adenocarcinoma. Br J Cancer (2000) 0.85
Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. Am J Hematol (1991) 0.85
Further observations on the preparation of antiglobulin reagents reacting with c3d and c4d on red cells. Vox Sang (1977) 0.85
Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant. Transfus Med (1999) 0.84
Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies. Br J Haematol (1980) 0.84
Intraarticular methylprednisolone therapy in hemophilic arthropathy. Am J Hematol (1988) 0.83
Comparison of platelet immunity in patients with SLE and with ITP. Transfus Sci (2000) 0.83
Autoimmune hemolytic anemia: a history. Transfus Med Rev (2000) 0.83
Epidural anesthesia in pregnant patients with low platelet counts. Obstet Gynecol (1988) 0.83
Purification and characterization of human platelet glutathione-S-transferase. Blood (1986) 0.82
Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity. J Thromb Haemost (2006) 0.82
Somatostatin stimulates coupled sodium chloride influx across the brush border of the rabbit ileum. Biochem Biophys Res Commun (1980) 0.82
Transfusion-related acute lung injury (TRALI). Vox Sang (2001) 0.82
Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds. Ann N Y Acad Sci (1989) 0.82
An investigation of cognitive function in relation to psychosocial variables in institutionalized old people. Can J Psychol (1987) 0.82
Acoustic nerve conduction abnormalities in Guillain-Barré syndrome. Neurology (1988) 0.82
Platelet activation in warm and cold heart surgery. Ann Thorac Surg (1995) 0.82
Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Br J Haematol (1998) 0.81
Anterior uveitis in Bantu children. Br J Ophthalmol (1973) 0.81
Autoimmune hemolytic anemia with concurrence of warm and cold red cell autoantibodies and a warm hemolysin. Transfusion (1985) 0.81
Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions. Transfus Med (2000) 0.81
Incidence of uveitis in Bantu-speaking negroes of South Africa. Br J Ophthalmol (1974) 0.81
Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I-II study. Ann Oncol (2007) 0.81
Bronchiolitis obliterans with organizing pneumonia and cold agglutinin disease associated with phenytoin hypersensitivity syndrome. Chest (1997) 0.81
Characterization of red blood cells strongly coated in vitro by C3 via the alternative pathway. Transfusion (1980) 0.81
Quantification of platelet activation status by analyzing P-selectin expression. Biochem Biophys Res Commun (2000) 0.81
Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation. J Biol Chem (1997) 0.81